SAN DIEGO, April 26 /PRNewswire-FirstCall/ -- Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that it will report its operating results for the first quarter of fiscal 2010 on Monday, May 3.
